Metachromatic Leukodystrophy. Case Presentation

Lina María Espejo; Ricardo de la Espriella; José Fernando Hernández

doi:10.1016/j.rcp.2016.05.001

Metachromatic Leukodystrophy. Case Presentation

Título traducido de la contribución: Leucodistrofia metacromática. Presentación de caso

Lina María Espejo
, Ricardo de la Espriella
, José Fernando Hernández

Departamento de Psiquiatría y Salud Mental

Clínica Nuestra Señora de la Paz
Médico especialista en neurología

Producción: Contribución a una revista › Artículo › revisión exhaustiva

9 Citas (Scopus)

Resumen

Metachromatic leukodystrophy (MLD) is a rare demyelinating disease (prevalence 1:40 000), also called arylsulfatase A deficiency (ARS-A), which may present with neurological and psychiatric symptoms. Clinical assessment may be difficult, due to unspecific signs and symptoms. A case is presented of a 16 year-old female patient seen in psychiatry due to behavioural changes, psychosis, and with impaired overall performance. She was initially diagnosed with schizophrenia, but the Nuclear Magnetic Resonance (NMR) scan and laboratory tests lead to the diagnosis of MLD.

Título traducido de la contribución	Leucodistrofia metacromática. Presentación de caso
Idioma original	Inglés
Páginas (desde-hasta)	44-49
Número de páginas	6
Publicación	Revista Colombiana de Psiquiatria
Volumen	46
N.º	1
DOI	https://doi.org/10.1016/j.rcp.2016.05.001
Estado	Publicada - 01 ene 2017

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1016/j.rcp.2016.05.001

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{c91df341fa8e41ef80ac76d2c450b8bf,

title = "Metachromatic Leukodystrophy. Case Presentation",

abstract = "Metachromatic leukodystrophy (MLD) is a rare demyelinating disease (prevalence 1:40 000), also called arylsulfatase A deficiency (ARS-A), which may present with neurological and psychiatric symptoms. Clinical assessment may be difficult, due to unspecific signs and symptoms. A case is presented of a 16 year-old female patient seen in psychiatry due to behavioural changes, psychosis, and with impaired overall performance. She was initially diagnosed with schizophrenia, but the Nuclear Magnetic Resonance (NMR) scan and laboratory tests lead to the diagnosis of MLD.",

keywords = "Demyelinating disease, Metachromatic leukodystrophy, Psychosis",

author = "Espejo, \{Lina Mar{\'i}a\} and \{de la Espriella\}, Ricardo and Hern{\'a}ndez, \{Jos{\'e} Fernando\}",

note = "Publisher Copyright: {\textcopyright} 2016 Asociaci{\'o}n Colombiana de Psiquiatr{\'i}a",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/j.rcp.2016.05.001",

language = "English",

volume = "46",

pages = "44--49",

journal = "Revista Colombiana de Psiquiatria",

issn = "0034-7450",

publisher = "Asociacion Colombiana de Psiquiatria",

number = "1",

}

TY - JOUR

T1 - Metachromatic Leukodystrophy. Case Presentation

AU - Espejo, Lina María

AU - de la Espriella, Ricardo

AU - Hernández, José Fernando

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Metachromatic leukodystrophy (MLD) is a rare demyelinating disease (prevalence 1:40 000), also called arylsulfatase A deficiency (ARS-A), which may present with neurological and psychiatric symptoms. Clinical assessment may be difficult, due to unspecific signs and symptoms. A case is presented of a 16 year-old female patient seen in psychiatry due to behavioural changes, psychosis, and with impaired overall performance. She was initially diagnosed with schizophrenia, but the Nuclear Magnetic Resonance (NMR) scan and laboratory tests lead to the diagnosis of MLD.

AB - Metachromatic leukodystrophy (MLD) is a rare demyelinating disease (prevalence 1:40 000), also called arylsulfatase A deficiency (ARS-A), which may present with neurological and psychiatric symptoms. Clinical assessment may be difficult, due to unspecific signs and symptoms. A case is presented of a 16 year-old female patient seen in psychiatry due to behavioural changes, psychosis, and with impaired overall performance. She was initially diagnosed with schizophrenia, but the Nuclear Magnetic Resonance (NMR) scan and laboratory tests lead to the diagnosis of MLD.

KW - Demyelinating disease

KW - Metachromatic leukodystrophy

KW - Psychosis

UR - https://www.scopus.com/pages/publications/85008178842

U2 - 10.1016/j.rcp.2016.05.001

DO - 10.1016/j.rcp.2016.05.001

M3 - Article

C2 - 28193373

AN - SCOPUS:85008178842

SN - 0034-7450

VL - 46

SP - 44

EP - 49

JO - Revista Colombiana de Psiquiatria

JF - Revista Colombiana de Psiquiatria

IS - 1

ER -

Metachromatic Leukodystrophy. Case Presentation

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto